BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18074761)

  • 21. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
    Pelzer F; Tröger W; Nat DR
    J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
    Maier G; Fiebig HH
    Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients.
    Bock PR; Hanisch J; Matthes H; Zänker KS
    Inflamm Allergy Drug Targets; 2014; 13(2):105-11. PubMed ID: 24766319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
    Gorter RW; van Wely M; Stoss M; Wollina U
    Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.
    Braedel-Ruoff S
    Forsch Komplementmed; 2010 Apr; 17(2):63-73. PubMed ID: 20484913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
    Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
    Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
    Maldacker J
    Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador.
    Kuttan G; Menon LG; Kuttan R
    Carcinogenesis; 1996 May; 17(5):1107-9. PubMed ID: 8640920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
    [No Abstract]   [Full Text] [Related]  

  • 31. Patients are talking about ... Iscador (mistletoe).
    Decker G
    Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
    Melzer J; Iten F; Hostanska K; Saller R
    Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
    Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
    [No Abstract]   [Full Text] [Related]  

  • 35. Pleura carcinosis. Cytomorphological findings with the mistletoe preparation iscador and other pharmaceuticals.
    Salzer G
    Oncology; 1986; 43 Suppl 1():66-70. PubMed ID: 3808576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Viscum album L. (Iscador) in the cat: tolerance, adverse reactions and indications].
    Glardon ; Pache ; Magnenat ; Pin ; Parvis
    Schweiz Arch Tierheilkd; 2014 Aug; 156(8):381-8. PubMed ID: 25082635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunostimulatory properties of mistletoe extracts and their application in oncology].
    Wrotek S; Skawiński R; Kozak W
    Postepy Hig Med Dosw (Online); 2014 Oct; 68():1216-24. PubMed ID: 25380204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador).
    Kovacs E; Hajto T; Hostanska K
    Eur J Cancer; 1991; 27(12):1672-6. PubMed ID: 1782081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial.
    Piao BK; Wang YX; Xie GR; Mansmann U; Matthes H; Beuth J; Lin HS
    Anticancer Res; 2004; 24(1):303-9. PubMed ID: 15015612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.